Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

The chart below compares the forward price to earnings (P/E) ratio of AstraZeneca to multiples in a peer set of leading ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after ...

The excitement around the new weight-loss industry is overtaking other disease areas and portfolios for publicly traded ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.

Leigh-Anne Lagden, 26, opened up about being hospitalized after accidentally overdosing on knockoff weight loss injections ...

Analysts cited data from a phase one study showing the highest dose of Amgen’s MariTide was linked to roughly 4% loss of bone ...